Arrowhead Pharmaceuticals Inc

Healthcare · Biotechnology

66.50$ -1.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Arrowhead Pharmaceuticals Inc (ARWR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,385 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARWR
Line item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	183	132	128	104	112	350	523	710	692	766	1,140	1,385
Current Assets	155	103	91	68	79	265	322	385	405	420	695	951
Cash	133	81	85	25	30	222	144	184	108	111	103	227
Cash & Short-Term Investments	154	99	85	66	77	259	315	368	376	404	681	919
Receivables	0.1	0.1	0.1	0.1	0.3	0.7	0.8	10	1.4	0.0	0.0	6.8
Inventory	0.0	0.0	1.3	0.9	1.3	3.3	4.3	4.4	-22	–	–	–
Property, Plant & Equipment	3.9	4.5	15	16	14	23	31	49	110	336	–	–
Goodwill	1.0	25	22	20	19	17	15	–	–	–	–	–
Intangible Assets	1.0	25	22	20	19	17	15	14	12	10	8.6	6.9
Total Liabilities	17	23	33	23	16	106	61	301	274	478	949	882
Current Liabilities	12	16	26	19	12	97	41	147	139	105	103	195
Short-Term Debt	0.3	0.2	0.2	0.2	0.2	12	1.1	2.3	2.8	11	6.3	47
Accounts Payable	2.6	5.0	12	4.1	2.8	7.6	6.8	9.5	2.9	36	11	18
Long-Term Debt	0.8	0.5	2.5	2.3	2.1	–	–	–	–	–	393	215
Shareholders' Equity	167	110	96	81	96	245	462	409	399	271	185	466
Retained Earnings	-225	-317	-398	-433	-487	-419	-504	-645	-821	-1,026	-1,626	-1,627
Shares Outstanding	47	57	61	74	84	99	101	104	105	107	120	134

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings